Alps Advisors Inc Summit Therapeutics Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.55 - $5.07 $95,579 - $190,033	-37,482 Reduced 7.04%	494,924 $2.05 Million
Q4 2023 Feb 14, 2024	BUY	$1.67 - $2.83 $29,176 - $49,442	17,471 Added 3.39%	532,406 $1.39 Million
Q3 2023 Nov 14, 2023	BUY	$1.54 - $2.42 $3,235 - $5,084	2,101 Added 0.41%	514,935 $962,000
Q2 2023 Aug 14, 2023	BUY	$1.32 - $2.81 $676,940 - $1.44 Million	512,834 New	512,834 $1.29 Million

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.6B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.